AEROVATE THERAPEUTICS INC (AVTE)
Institutional ownership reported to the SEC as of Q2 2025, across 17 quarters.
2
Reporting holders
$65.4K
Reported value
0.0%
Held as options
-74
Holder change
Options share is the part of reported value carried in derivative lines rather than shares. A high figure means institutions are expressing a view on this security without owning much of it.
Holders
| Filer | Value | Shares | Their book | Held | Change |
|---|---|---|---|---|---|
| Kovitz Investment Group Partners, LLC | $64.9K | 24,210 | 0.00% | 2q | -8.7%-$6.2K |
| Alamea Verwaltungs GmbH | $512 | 204 | 0.00% | 2q | HELD |
Quarter by quarter
Coverage begins with the quarter ending 2018-12-31. Earlier filings exist only as occasional late amendments, too sparse to describe a market, so they are not shown.
| Quarter | Holders | Value | Shares | New | Added | Trimmed | Options |
|---|---|---|---|---|---|---|---|
| Q2 2025 | 2 | $65.4K | 24,414 | 0 | 0 | 1 | 0.0% |
| Q1 2025 | 76 | $79.7M | 31,678,138 | 8 | 25 | 18 | 0.3% |
| Q4 2024 | 75 | $80.7M | 29,985,724 | 20 | 23 | 12 | 1.5% |
| Q3 2024 | 68 | $56.4M | 26,839,122 | 10 | 21 | 16 | 0.5% |
| Q2 2024 | 78 | $45.3M | 26,848,006 | 29 | 27 | 11 | 1.6% |
| Q1 2024 | 76 | $842.3M | 28,486,085 | 20 | 17 | 21 | 0.0% |
| Q4 2023 | 60 | $640.2M | 28,289,927 | 5 | 22 | 12 | 0.0% |
| Q3 2023 | 54 | $385.3M | 28,390,073 | 2 | 22 | 11 | 0.0% |
| Q2 2023 | 56 | $487.0M | 28,395,533 | 4 | 21 | 13 | 0.0% |
| Q1 2023 | 55 | $500.7M | 24,821,882 | 5 | 19 | 19 | 0.0% |
| Q4 2022 | 55 | $731.5M | 24,965,936 | 21 | 12 | 14 | 0.0% |
| Q3 2022 | 54 | $447.4M | 26,982,699 | 10 | 20 | 15 | 0.0% |
| Q2 2022 | 49 | $403.0M | 25,779,605 | 8 | 7 | 24 | 0.0% |
| Q1 2022 | 45 | $475.5M | 25,942,328 | 8 | 14 | 11 | 0.0% |
| Q4 2021 | 47 | $301.8M | 25,600,620 | 8 | 15 | 9 | 0.0% |
| Q3 2021 | 41 | $452.6M | 21,654,813 | 29 | 3 | 4 | 0.0% |
| Q2 2021 | 18 | $454.4M | 19,965,342 | 18 | 0 | 0 | 0.0% |